ebook Munafa Stock Market Course + Intraday & FNO calls  

       

AUPH announcements Aurinia Pharmaceuticals Inc announcements and dividends declared USA

Aurinia Pharmaceuticals Inc Complete list of announcements declared & dividend announcements by Aurinia Pharmaceuticals Inc AUPH

Aurinia Pharmaceuticals Inc AUPH listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Aurinia Pharmaceuticals Inc AUPH

Aurinia Pharmaceuticals (AUPH) Q2 Earnings Miss Estimates
Aurinia (AUPH) delivered earnings and revenue surprises of -5.88% and +10.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Announcement as on 31 July 2025

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates
Aurinia (AUPH) delivered earnings and revenue surprises of 100% and 2.63%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Announcement as on 12 May 2025

Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates
Aurinia (AUPH) delivered earnings and revenue surprises of 200% and 0.25%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Announcement as on 27 February 2025

Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates
Aurinia Pharmaceuticals (AUPH) came out with a quarterly loss of [CO].09 per share versus the Zacks Consensus Estimate of a loss of [CO].17. This compares to loss of [CO].06 per share a year ago. These figures are adjusted for non-recur
Announcement as on 02 November 2023

Aurinia Pharmaceuticals Share Surge Shows Investor Support for Board Reboot, Strategic Review
Shares of Aurinia Pharmaceuticals (US:AUPH) are up almost 14% in Friday’s premarket activity following a series of director departures and news of a strategic review of potential sale or merger opportunities.Exiting the board of the Edmonton, Alberta
Announcement as on 30 June 2023

Announcements by Aurinia Pharmaceuticals Inc first page | Next page |

AUPH Aurinia Pharmaceuticals Inc current price & indicator signals

Moving Averages for Aurinia Pharmaceuticals Inc

  • 5Day Average: 15.58
  • 12Day Average: 15.74
  • 20Day Average: 15.56
  • 50Day Average: 13.44
  • 100Day Average: 12.45
  • 150Day Average: 11.02
  • 200Day Average: 10.26

AUPH Indicators & signals

Indicator MACD (12,26,9)

15.57, 14.95, 0.77
Indicator MACD is in positive zone

Indicator ADX (14)

16.13, 27.69, 20
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of AUPH Aurinia Pharmaceuticals Inc are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 15.62 14.98 to 15.65 2.02% 0.89 times
04 Thu Dec 2025 15.31 14.76 to 15.35 2.68% 0.64 times
03 Wed Dec 2025 14.91 14.70 to 15.61 -6.29% 1.81 times
02 Tue Dec 2025 15.91 15.84 to 16.25 -1.61% 0.89 times
01 Mon Dec 2025 16.17 15.94 to 16.32 0.31% 1.2 times
28 Fri Nov 2025 16.12 16.01 to 16.37 -1.53% 0.51 times
26 Wed Nov 2025 16.37 16.14 to 16.48 0.55% 0.84 times
25 Tue Nov 2025 16.28 15.79 to 16.29 1.06% 0.84 times
24 Mon Nov 2025 16.11 15.64 to 16.21 2.74% 1.42 times
21 Fri Nov 2025 15.68 14.94 to 15.75 3.57% 1.07 times
20 Thu Nov 2025 15.14 15.10 to 15.60 -0.39% 0.79 times
19 Wed Nov 2025 15.20 15.10 to 15.81 -1.94% 1.36 times

Videos related to: AUPH announcements Aurinia Pharmaceuticals Inc announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

AUPH announcements Aurinia Pharmaceuticals Inc announcements and dividends declared USA

 

Back to top